Cirrhosis/Liver Failure News

Targeted human albumin solution increased serum sodium in hospitalized patients with cirrhosis and hyponatremia, according to prospective data presented at the International Liver Congress.

Intravenous ferric carboxymaltose corrected iron deficiency anemia among patients with advanced cirrhosis, according to a late breaking presentation at the International Liver Congress.

Transarterial radioembolization was a well-tolerated first-line treatment among patients with hepatocellular carcinoma, according to research presented at the International Liver Congress.

A treatment regimen of low dose VBI-2601 (BRII-179) injections in patients with chronic hepatitis B exhibited positive safety, tolerability and efficacy, according to a poster presented at the International Liver Congress.

Researchers found Latin American countries with more alcohol policies had lower alcohol consumption per capita, deaths due to traffic injuries and alcohol-associated cirrhosis, according to a presenter at the International Liver Congress.

Glucose variability was an independent predictor of hepatocellular carcinoma, according to research presented at The International Liver Congress.

Researchers validated a liver cancer risk test algorithm for identifying patients with chronic hepatitis C at low risk for hepatocellular carcinoma, according to a study presented at The Digital International Liver Congress.

Using clinical bloodwork like FIB-4 and elastography technology in combination, Researchers at the International Liver congress proposed they could better identify patients with advanced fibrosis using clinical bloodwork like FIB-4 and elastography technology in combination.

A single, intravenous infusion of GNT0003, an adeno-associated virus vector serotype 8, restored gene expression among patients with Crigler Najjar syndrome, according to a late breaker presentation at the International Liver Congress.

The C-reactive protein and alpha-fetoprotein in immunotherapy score identified patients with favorable hepatocellular carcinoma disease control and survival, according to a study presented at the International Liver Congress.